G. W. Torrance

1.3k total citations
16 papers, 1.0k citations indexed

About

G. W. Torrance is a scholar working on Pediatrics, Perinatology and Child Health, Public Health, Environmental and Occupational Health and Pharmacology. According to data from OpenAlex, G. W. Torrance has authored 16 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pediatrics, Perinatology and Child Health, 4 papers in Public Health, Environmental and Occupational Health and 3 papers in Pharmacology. Recurrent topics in G. W. Torrance's work include Childhood Cancer Survivors' Quality of Life (4 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Inflammatory mediators and NSAID effects (2 papers). G. W. Torrance is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (4 papers), Health Systems, Economic Evaluations, Quality of Life (2 papers) and Inflammatory mediators and NSAID effects (2 papers). G. W. Torrance collaborates with scholars based in Canada, United States and Australia. G. W. Torrance's co-authors include William Furlong, David Feeny, Michael Boyle, Sheila Weitzman, Peter Rosenbaum, David Feeny, RD Barr, Margaret L. McNeely, David J. Magee and Ronald D. Barr and has published in prestigious journals such as Journal of Clinical Oncology, Osteoarthritis and Cartilage and Medical Decision Making.

In The Last Decade

G. W. Torrance

14 papers receiving 978 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
G. W. Torrance Canada	8	479	308	249	184	107	16	1.0k
Sonja Depauw Canada	7	662 1.4×	181 0.6×	366 1.5×	156 0.8×	125 1.2×	10	1.2k
B. R. Catchlove Australia	6	301 0.6×	213 0.7×	255 1.0×	264 1.4×	80 0.7×	14	1.3k
Carla DeMuro United States	16	280 0.6×	114 0.4×	146 0.6×	99 0.5×	52 0.5×	65	1.1k
Heleen M.E. van Agt Netherlands	12	247 0.5×	129 0.4×	257 1.0×	110 0.6×	45 0.4×	17	1.3k
Claudette G. Varricchio United States	13	133 0.3×	143 0.5×	212 0.9×	231 1.3×	82 0.8×	28	1.0k
Jessica Roydhouse Australia	16	175 0.4×	103 0.3×	203 0.8×	179 1.0×	98 0.9×	72	879
Claudia Rutherford Australia	21	126 0.3×	125 0.4×	216 0.9×	213 1.2×	114 1.1×	88	1.2k
Courtney Williams United States	21	349 0.7×	133 0.4×	297 1.2×	384 2.1×	48 0.4×	110	1.3k
D Whalley United Kingdom	14	302 0.6×	55 0.2×	288 1.2×	86 0.5×	52 0.5×	27	2.0k
Daniel Vail United States	20	128 0.3×	212 0.7×	149 0.6×	171 0.9×	31 0.3×	70	1.1k

Countries citing papers authored by G. W. Torrance

Since Specialization

Citations

This map shows the geographic impact of G. W. Torrance's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. W. Torrance with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. W. Torrance more than expected).

Fields of papers citing papers by G. W. Torrance

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. W. Torrance. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. W. Torrance. The network helps show where G. W. Torrance may publish in the future.

Co-authorship network of co-authors of G. W. Torrance

This figure shows the co-authorship network connecting the top 25 collaborators of G. W. Torrance. A scholar is included among the top collaborators of G. W. Torrance based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. W. Torrance. G. W. Torrance is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

Horsman, John, et al.. (2013). Health Utilities Index (Hui®): Population Reference Statistics. Value in Health. 16(7). A595–A595. 3 indexed citations

Goldsmith, C. H., et al.. (2004). Abstracts. Osteoarthritis and Cartilage. 12. 1–148. 8 indexed citations

Torrance, G. W., et al.. (2004). PIN26 VALIDATION OF 5-ITEM INSTRUMENT FOR ASSESSING SYMPTOM SEVERITY IN PATIENTS WITH ACUTE BACTERIAL SINUSITIS. Value in Health. 7(6). 766–766. 1 indexed citations

Torrance, G. W., Philip A. Band, J.-P. Raynauld, et al.. (2003). Response to Dr C. Daniel Mullins’ letter [re: Osteoarthritis and Cartilage, 2002; 10:518–27]. Osteoarthritis and Cartilage. 11(5). 379–381. 1 indexed citations

McNeely, Margaret L., G. W. Torrance, & David J. Magee. (2003). A systematic review of physiotherapy for spondylolysis and spondylolisthesis. Manual Therapy. 8(2). 80–91. 55 indexed citations

Bellamy, Nicholas, M. J. Bell, C. H. Goldsmith, et al.. (2003). Symptom free response using the WOMAC pain score in patients treated with hylan G-F 20 for knee osteoarthritis. Queensland's institutional digital repository (The University of Queensland). 11. 1 indexed citations

Torrance, G. W.. (2002). Looking Back and Looking Forward: Viewed through the Eyes of George Torrance. Medical Decision Making. 22(2). 178–181. 1 indexed citations

Raynauld, J. P., Nicholas Bellamy, C. H. Goldsmith, et al.. (2002). An evaluation of the safety and effectiveness of repeat courses of hylan G-F 20 for treating patients with knee osteoarthritis. Queensland's institutional digital repository (The University of Queensland). 10. 1 indexed citations

Raynauld, J. P., Nicholas Bellamy, C. H. Goldsmith, et al.. (2000). A prospective randomized health outcomes trial of hylan G-F 20 in the treatment of patients with knee osteoarthritis. Queensland's institutional digital repository (The University of Queensland). 43(9). 1 indexed citations

10.

Torrance, G. W., et al.. (1996). Canadian Guidelines for Economic Evaluation of Pharmaceuticals. PharmacoEconomics. 9(6). 535–559. 111 indexed citations

11.

Barr, Ronald D., William Furlong, John Horsman, et al.. (1996). The monetary costs of childhood cancer to the families of patients. International Journal of Oncology. 8(5). 933–40. 42 indexed citations

12.

Torrance, G. W., William Furlong, David Feeny, & Michael Boyle. (1995). Multi-Attribute Preference Functions. PharmacoEconomics. 7(6). 503–520. 439 indexed citations

13.

Barr, Ronald D., William Furlong, Susan Dawson, et al.. (1993). An assessment of global health status in survivors of acute lymphoblastic leukemia in childhood.. PubMed. 15(3). 284–90. 87 indexed citations

14.

Riedemann, Pablo, et al.. (1993). A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: a meta-analysis.. PubMed. 20(12). 2095–103. 17 indexed citations

15.

Feeny, David, William Furlong, RD Barr, et al.. (1992). A comprehensive multiattribute system for classifying the health status of survivors of childhood cancer.. Journal of Clinical Oncology. 10(6). 923–928. 270 indexed citations

16.

Covvey, H. Dominic, et al.. (1980). Computer-assisted medicine: economics of computing (part 1).. PubMed. 123(4). 322–4.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact